SCHEMBL21114435

SCHEMBL21114435

O=CC(O)C(O)CO.O=CC(O)C(O)CO

nearest known ligand 0.50

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 1/20 0.50
MPI P34949 1/20 0.44
LMNA P02545 3/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
TDP1 Q9NUW8 2/20 0.40
PDE4A P27815 1/20 0.35
USP2 O75604 1/20 0.32
SLCO1B1 Q9Y6L6 1/20 0.32
ALDH1A1 P00352 1/20 0.32
OR51E2 Q9H255 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23308 1.00
SCHEMBL799754 1.00
SCHEMBL15281293 1.00
SCHEMBL424699 1.00
SCHEMBL21114434 1.00 AKR1B1 (0.50) AKR1B1MPILMNAL3MBTL1TDP1
SCHEMBL42624 1.00
SCHEMBL117909 1.00
SCHEMBL15321644 1.00 AKR1B1 (0.50) AKR1B1MPILMNAL3MBTL1TDP1
Methane SCHEMBL23200369 0.97
E968 SCHEMBL18341323 0.97 AKR1B1 (0.48) AKR1B1MPILMNAL3MBTL1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190214145-A1 Method and systems for creating and screening patient metabolite profile to diagnose current medical condition, diagnose current treatment state and recommend new treatment regimen KUREK ITZHAK (US) 2019-07-11 US disclosed